Dover Street Market x Nike Air Superfly Returns in Bold 'Hyper Pink' Makeover
Dover Street Markethas just unveiled its latest collaboration with Nike — a bold rework of the recently revivedNike Air Superfly, now dressed in an electrifying 'Hyper Pink' colorway. Marking a striking departure from their priormonochromatic releasesin 'Hyper Black', 'Summit White', and 'Smoke Grey', this edition commands attention with vibrant hues and unexpected contrasts.
The silhouette stays true to its roots with a perforated leather upper, while bold pink side panels immediately draw the eye. A black leather tongue and toe box add depth, grounding the otherwise high-octane palette. Below, the midsole comes dipped in blazing total orange, fading into a fiery sunset effect. Volt green hits along the outsole inject an added jolt of energy, making the design feel as dynamic as it looks.
DSM's signature hut logo is stamped on the tongue, accompanied by Nike Swooshes on the heel, lateral collar, and right tongue — subtle nods that highlight the co-branded nature of the design.
The DSM x Nike Superfly 'Hyper Pink' stands out as a vibrant reinterpretation of an archival silhouette, blending bold modern styling with performance-driven roots. A head-turner from every angle, this drop reinforces DSM's sharp eye for contemporary streetwear evolution.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
The IMA Group Acquires New York's Medical Research Network
IMA Clinical Research continues to grow; acquisition adds CNS research site in NYC and expands access to promising clinical trials to patients in high-need therapeutic areas TARRYTOWN, N.Y., July 21, 2025--(BUSINESS WIRE)--The IMA Group (IMA) today announced the acquisition of Medical Research Network (MRN) LLC, a U.S.-based clinical research site located in New York City, specializing in psychiatry and neurology trials focused on central nervous system (CNS) disorders. Terms of the transaction were not disclosed. Founded in 1997, MRN will continue operating under its current name and leadership, with core investigators and staff remaining in place, led by Founder, CEO, and Principal Investigator Michael R. Liebowitz, MD. Dr. Liebowitz is Board Certified in Psychiatry and has devoted more than 30 years to the research and treatment of anxiety, phobic, and affective disorders. He previously chaired the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) Workgroup on Anxiety Disorders. His contributions to the psychiatric and research fields span social anxiety, obsessive-compulsive disorder, panic disorder, atypical depression, and rapid cycling mood disorders. "The need for high-quality clinical research in mental health continues to grow, particularly as we confront rising demand for care and long-standing gaps in access," said Dr. Liebowitz. "By combining our deep CNS expertise and well-established clinical operations with IMA's growing national platform, we're positioned to reach more diverse and underserved patient populations, accelerate access to promising treatments, and deliver outstanding value to sponsors." Mark Weinberger, PhD, MPH, President and CEO of The IMA Group, emphasized how the acquisition enhances IMA's operational capacity to meet sponsor needs. "By integrating MRN's experienced team and established site into our network, we're strengthening our ability to deliver efficient, high-performing trials in the CNS space," he said. "This addition helps us reduce time to first patient, ensure quality data capture, and provide the scale and consistency that today's sponsors require to execute successful studies." The acquisition adds IMA's second research site in New York City and its first East Coast location dedicated to CNS trials. It builds on IMA's existing CNS-focused presence in Phoenix, Las Vegas, and Albuquerque—expanding the company's national footprint in this key therapeutic area. The move also aligns with the company's broader strategy to grow both organically and through acquisitions—positioning IMA as one of the nation's leading independent providers of outsourced healthcare evaluation and clinical research services. About The IMA Group:For over 30 years, The IMA Group, headquartered in New York, has been focused on enhancing the livelihood and productivity of individuals and organizations through a comprehensive range of Medical and Behavioral Health Services and Clinical Research at more than 150 sites and our large, affiliated provider network. The IMA Group serves the nation's top government and payer organizations through a range of Occupational Health, Workers' Compensation, Auto Insurance, and Employer Solutions. The company's Evaluation Services spans disability and independent medical exams (IME), case management services, fitness for duty/pre-employment evaluations, medical/psychological/ancillary exams, and a variety of occupational health services. IMA Clinical Research offers site-based, hybrid, and fully decentralized clinical trials that support the development of novel medicines, vaccines, and devices. Additionally, The IMA Group is unique in the marketplace in that it can bring together expertise in Evaluation Services and Clinical Research. For more information, visit or View source version on Contacts For more information, contact: Brenna Harrington706-217-7809brenna@
Hypebeast
4 days ago
- Hypebeast
Official Look at the Nike Air Monarch IV "Wheat"
Name:Nike Air Monarch IV 'Wheat'Colorway:Wheat/Gum Medium Brown-BlackSKU:IB2281-700MSRP:TBDRelease Date:Fall 2025Where to Buy:Nike Nikeis embracing the changing seasons by dressing its perennial 'dad shoe,' theNike Air Monarch IV, in a warm and versatile 'Wheat' colorway. Set to drop in Fall 2025, this seasonal update brings a rugged yet stylish aesthetic to a silhouette celebrated for its comfort and enduring appeal. The Air Monarch IV has long been a staple, cherished for its supportive build and plush cushioning. The 'Wheat' iteration leans into a popular autumn-inspired palette, drenching the shoe in rich, earthy tones. It features a robust leather upper in a deep wheat hue, creating a monochromatic yet textured look that's perfect for the cooler months. Subtle tonal stitching and overlays enhance the shoe's classic design lines, while a contrasting gum rubber outsole provides a timeless finish and reliable traction. Beyond its fresh aesthetic, the Air Monarch IV maintains the comfort and practicality that have made it a favorite across generations. Its Phylon midsole and full-length encapsulated Air-Sole unit ensure comfortable cushioning and support for all-day wear. The durable rubber outsole offers excellent grip on various surfaces, making it a versatile choice for both casual outings and light activities.
Hypebeast
7 days ago
- Hypebeast
Dover Street Market x Nike Air Superfly Returns in Bold 'Hyper Pink' Makeover
Name:Dover Street Market x Nike Air SuperflyColorway:Hyper Pink/Total Orange-BlackSKU:IB1403-600MSRP:$100Release Date:2025Where to Buy:Dover Street Market Dover Street Markethas just unveiled its latest collaboration with Nike — a bold rework of the recently revivedNike Air Superfly, now dressed in an electrifying 'Hyper Pink' colorway. Marking a striking departure from their priormonochromatic releasesin 'Hyper Black', 'Summit White', and 'Smoke Grey', this edition commands attention with vibrant hues and unexpected contrasts. The silhouette stays true to its roots with a perforated leather upper, while bold pink side panels immediately draw the eye. A black leather tongue and toe box add depth, grounding the otherwise high-octane palette. Below, the midsole comes dipped in blazing total orange, fading into a fiery sunset effect. Volt green hits along the outsole inject an added jolt of energy, making the design feel as dynamic as it looks. DSM's signature hut logo is stamped on the tongue, accompanied by Nike Swooshes on the heel, lateral collar, and right tongue — subtle nods that highlight the co-branded nature of the design. The DSM x Nike Superfly 'Hyper Pink' stands out as a vibrant reinterpretation of an archival silhouette, blending bold modern styling with performance-driven roots. A head-turner from every angle, this drop reinforces DSM's sharp eye for contemporary streetwear evolution.
